US Stock MarketDetailed Quotes

PSTX Poseida Therapeutics

Watchlist
  • 3.690
  • -0.020-0.54%
Close Nov 12 16:00 ET
  • 3.720
  • +0.030+0.81%
Post 16:23 ET
359.65MMarket Cap-5857P/E (TTM)

Poseida Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
29.78%25.97M
172.09%28.14M
-50.42%64.7M
148.68%25M
-91.96%9.35M
641.22%20.01M
620.77%10.34M
317.73%130.49M
-67.82%10.05M
116.31M
Operating revenue
29.78%25.97M
172.09%28.14M
-50.42%64.7M
148.68%25M
-91.96%9.35M
641.22%20.01M
620.77%10.34M
317.73%130.49M
-67.82%10.05M
--116.31M
Cost of revenue
Gross profit
Operating expense
20.60%57.73M
5.74%52.72M
1.98%194.21M
17.64%50.9M
2.35%45.57M
8.19%47.87M
-14.62%49.86M
10.30%190.44M
-11.17%43.27M
7.06%44.53M
Selling and administrative expenses
40.41%12.18M
-17.02%9.8M
-0.28%37.44M
-5.43%8.86M
-13.81%8.09M
-6.07%8.68M
23.69%11.81M
4.52%37.54M
-2.51%9.37M
3.56%9.39M
-General and administrative expense
40.41%12.18M
-17.02%9.8M
-0.28%37.44M
-5.43%8.86M
-13.81%8.09M
-6.07%8.68M
23.69%11.81M
4.52%37.54M
-2.51%9.37M
3.56%9.39M
Research and development costs
16.22%45.55M
12.80%42.92M
2.53%156.77M
24.01%42.05M
6.67%37.48M
11.95%39.19M
-22.10%38.05M
11.82%152.9M
-13.30%33.9M
8.03%35.14M
Operating profit
-14.00%-31.76M
37.80%-24.58M
-116.03%-129.5M
22.01%-25.91M
-150.46%-36.22M
32.95%-27.86M
30.63%-39.52M
57.61%-59.95M
-90.07%-33.22M
272.59%71.78M
Net non-operating interest income expense
-5.51%-2.26M
-11.09%-2.25M
-36.12%-8.67M
-14.78%-2.27M
-25.97%-2.24M
-38.76%-2.14M
-88.30%-2.03M
-89.70%-6.37M
-135.12%-1.98M
-112.07%-1.78M
Non-operating interest expense
5.51%2.26M
11.09%2.25M
36.12%8.67M
14.78%2.27M
25.97%2.24M
38.76%2.14M
88.30%2.03M
89.70%6.37M
135.12%1.98M
112.07%1.78M
Other net income (expense)
4.09%2.64M
-5.23%2.56M
419.66%14.85M
30.28%2.83M
934.60%6.79M
4,784.62%2.54M
14,294.74%2.7M
-85.56%2.86M
-89.03%2.17M
21,766.67%656K
Other non- operating income (expenses)
4.09%2.64M
-5.23%2.56M
419.66%14.85M
30.28%2.83M
934.60%6.79M
4,784.62%2.54M
14,294.74%2.7M
-85.56%2.86M
-89.03%2.17M
21,766.67%656K
Income before tax
-14.26%-31.37M
37.51%-24.27M
-94.34%-123.32M
23.25%-25.35M
-144.82%-31.67M
36.20%-27.46M
33.09%-38.85M
49.22%-63.46M
-2,348.20%-33.03M
266.56%70.66M
Income tax
-80.33%107K
0
-57.54%107K
544K
292K
252K
Net income
-14.26%-31.37M
37.51%-24.27M
-92.85%-123.43M
23.92%-25.35M
-145.13%-31.78M
36.20%-27.46M
33.09%-38.85M
48.79%-64M
-2,368.07%-33.32M
265.97%70.41M
Net income continuous Operations
-14.26%-31.37M
37.51%-24.27M
-92.85%-123.43M
23.92%-25.35M
-145.13%-31.78M
36.20%-27.46M
33.09%-38.85M
48.79%-64M
-2,368.07%-33.32M
265.97%70.41M
Minority interest income
Net income attributable to the parent company
-14.26%-31.37M
37.51%-24.27M
-92.85%-123.43M
23.92%-25.35M
-145.13%-31.78M
36.20%-27.46M
33.09%-38.85M
48.79%-64M
-2,368.07%-33.32M
265.97%70.41M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-14.26%-31.37M
37.51%-24.27M
-92.85%-123.43M
23.92%-25.35M
-145.13%-31.78M
36.20%-27.46M
33.09%-38.85M
48.79%-64M
-2,368.07%-33.32M
265.97%70.41M
Basic earnings per share
0.00%-0.32
44.44%-0.25
-53.93%-1.37
33.33%-0.26
-138.04%-0.35
53.62%-0.32
51.61%-0.45
55.72%-0.89
-2,050.00%-0.39
235.29%0.92
Diluted earnings per share
0.00%-0.32
44.44%-0.25
-53.93%-1.37
33.33%-0.26
-138.04%-0.35
53.62%-0.32
51.61%-0.45
55.72%-0.89
-2,050.00%-0.39
235.29%0.92
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 29.78%25.97M172.09%28.14M-50.42%64.7M148.68%25M-91.96%9.35M641.22%20.01M620.77%10.34M317.73%130.49M-67.82%10.05M116.31M
Operating revenue 29.78%25.97M172.09%28.14M-50.42%64.7M148.68%25M-91.96%9.35M641.22%20.01M620.77%10.34M317.73%130.49M-67.82%10.05M--116.31M
Cost of revenue
Gross profit
Operating expense 20.60%57.73M5.74%52.72M1.98%194.21M17.64%50.9M2.35%45.57M8.19%47.87M-14.62%49.86M10.30%190.44M-11.17%43.27M7.06%44.53M
Selling and administrative expenses 40.41%12.18M-17.02%9.8M-0.28%37.44M-5.43%8.86M-13.81%8.09M-6.07%8.68M23.69%11.81M4.52%37.54M-2.51%9.37M3.56%9.39M
-General and administrative expense 40.41%12.18M-17.02%9.8M-0.28%37.44M-5.43%8.86M-13.81%8.09M-6.07%8.68M23.69%11.81M4.52%37.54M-2.51%9.37M3.56%9.39M
Research and development costs 16.22%45.55M12.80%42.92M2.53%156.77M24.01%42.05M6.67%37.48M11.95%39.19M-22.10%38.05M11.82%152.9M-13.30%33.9M8.03%35.14M
Operating profit -14.00%-31.76M37.80%-24.58M-116.03%-129.5M22.01%-25.91M-150.46%-36.22M32.95%-27.86M30.63%-39.52M57.61%-59.95M-90.07%-33.22M272.59%71.78M
Net non-operating interest income expense -5.51%-2.26M-11.09%-2.25M-36.12%-8.67M-14.78%-2.27M-25.97%-2.24M-38.76%-2.14M-88.30%-2.03M-89.70%-6.37M-135.12%-1.98M-112.07%-1.78M
Non-operating interest expense 5.51%2.26M11.09%2.25M36.12%8.67M14.78%2.27M25.97%2.24M38.76%2.14M88.30%2.03M89.70%6.37M135.12%1.98M112.07%1.78M
Other net income (expense) 4.09%2.64M-5.23%2.56M419.66%14.85M30.28%2.83M934.60%6.79M4,784.62%2.54M14,294.74%2.7M-85.56%2.86M-89.03%2.17M21,766.67%656K
Other non- operating income (expenses) 4.09%2.64M-5.23%2.56M419.66%14.85M30.28%2.83M934.60%6.79M4,784.62%2.54M14,294.74%2.7M-85.56%2.86M-89.03%2.17M21,766.67%656K
Income before tax -14.26%-31.37M37.51%-24.27M-94.34%-123.32M23.25%-25.35M-144.82%-31.67M36.20%-27.46M33.09%-38.85M49.22%-63.46M-2,348.20%-33.03M266.56%70.66M
Income tax -80.33%107K0-57.54%107K544K292K252K
Net income -14.26%-31.37M37.51%-24.27M-92.85%-123.43M23.92%-25.35M-145.13%-31.78M36.20%-27.46M33.09%-38.85M48.79%-64M-2,368.07%-33.32M265.97%70.41M
Net income continuous Operations -14.26%-31.37M37.51%-24.27M-92.85%-123.43M23.92%-25.35M-145.13%-31.78M36.20%-27.46M33.09%-38.85M48.79%-64M-2,368.07%-33.32M265.97%70.41M
Minority interest income
Net income attributable to the parent company -14.26%-31.37M37.51%-24.27M-92.85%-123.43M23.92%-25.35M-145.13%-31.78M36.20%-27.46M33.09%-38.85M48.79%-64M-2,368.07%-33.32M265.97%70.41M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -14.26%-31.37M37.51%-24.27M-92.85%-123.43M23.92%-25.35M-145.13%-31.78M36.20%-27.46M33.09%-38.85M48.79%-64M-2,368.07%-33.32M265.97%70.41M
Basic earnings per share 0.00%-0.3244.44%-0.25-53.93%-1.3733.33%-0.26-138.04%-0.3553.62%-0.3251.61%-0.4555.72%-0.89-2,050.00%-0.39235.29%0.92
Diluted earnings per share 0.00%-0.3244.44%-0.25-53.93%-1.3733.33%-0.26-138.04%-0.3553.62%-0.3251.61%-0.4555.72%-0.89-2,050.00%-0.39235.29%0.92
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data

Concept Top Gainers Yesterday
Top Gainers Yesterday
Intraday-0.14%